Search
Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Australia: Nanotech to Battle Superbugs

Image Credits: UniSA, Press Release
Getting your Trinity Audio player ready...

Researchers from the RMIT University and the University of South Australia (UniSA) have developed an ultrathin superbug-fighting material that could revolutionise wound care and implant technology by preventing and healing bacterial infections. This groundbreaking innovation, which has already undergone advanced pre-clinical trials, demonstrates remarkable effectiveness against drug-resistant bacterial cells, including the notorious “golden staph” superbugs.

Antibiotic resistance poses a significant global health threat, causing approximately 700,000 deaths annually. Without the development of new antibacterial therapies, this number could skyrocket to 10 million deaths per year by 2050. In response to this looming crisis, a joint effort led by RMIT University, and the University of South Australia (UniSA) has explored the potential of black phosphorus-based nanotechnology as an advanced treatment for infections and wound healing.

The results of this research, published in Advanced Therapeutics, reveal that this nanotechnology can effectively treat infections by eliminating over 99% of bacteria without harming other cells in biological models. The treatment’s efficacy is comparable to that of traditional antibiotics, leading to accelerated healing, with wounds closing by 80% within just seven days.

What sets this superbug-killing nanotechnology apart is its versatility. RMIT University has sought patent protection for black phosphorus flakes, which can be integrated into a wide range of materials, including gels, plastics, and medical device components. This innovation isn’t just a simple coating; it becomes an integral part of these materials, rendering them antimicrobial.

Professor Sumeet Walia, co-lead researcher from RMIT, highlights the unique aspect of their invention. It doesn’t merely provide a protective coating; it integrates seamlessly into common materials used in medical devices and wound dressings. This integration ensures rapid antimicrobial action, followed by self-decomposition once the threat of infection has been eliminated.

The effectiveness of black phosphorus in killing microbes was initially discovered in a previous study led by RMIT. It was found to be particularly effective when applied in nano-thin layers on surfaces used for wound dressings and implants, such as cotton, titanium, and medical-grade plastics.

The science behind this invention revolves around black phosphorus, the most stable form of phosphorus. In its ultra-thin form, black phosphorus readily degrades in the presence of oxygen, making it an ideal candidate for microbial control.

Professor Walia explained the mechanism and said that as the nanomaterial undergoes degradation, its surface interacts with the surrounding atmosphere, leading to the generation of substances known as reactive oxygen species. These compounds play a crucial role in dismantling bacterial cells.

In their recent study, the researchers tested nano-thin flakes of black phosphorus against five common bacterial strains, including E. coli and drug-resistant golden staph. Their antimicrobial nanotechnology proved highly effective, swiftly annihilating more than 99% of bacterial cells, surpassing the performance of many existing infection treatments.

Dr. Aaron Elbourne, co-lead researcher from RMIT, underscores the urgency of developing new treatments to combat antibiotic resistance. Superbugs, which are bacteria resistant to antibiotics, pose significant health challenges globally, and as drug resistance grows, treating these infections becomes increasingly difficult.

In preclinical trials conducted by the team at UniSA, lead researcher Dr. Zlatko Kopecki demonstrated the effectiveness of daily topical application of black phosphorus nanoflakes in reducing infection. This treatment proved comparable to ciprofloxacin, a common antibiotic, in eradicating wound infections and accelerating healing. Wounds closed by an impressive 80% within just seven days.

Dr. Kopecki, a Channel 7 Children’s Research Foundation Fellow in Childhood Wound Infections, highlights the scarcity of antibiotic treatments and the urgent need for alternative approaches to manage wound infections. He believes that black phosphorus has the potential to revolutionise the treatment of chronic wounds.

The research team is eager to collaborate with potential industry partners to further develop and prototype this groundbreaking technology. In the face of escalating antibiotic resistance, their innovation holds promise as a powerful weapon in the global battle against superbugs.

PARTNER

Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.

PARTNER

CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.

PARTNER

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.

SUPPORTING ORGANISATION

SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.

PARTNER

HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 

PARTNER

IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.